Drs. Hossein Borghaei and Tony Calles dissect pivotal abstracts and cutting-edge data from the ESMO Congress 2023, spotlighting the transformative landscape of lung cancer treatment. From exploring innovative immunotherapy combinations to the promise of antibody-drug conjugates, they explore the complexities of neoadjuvant and adjuvant sequencing and shed light on optimal strategies. With a keen focus on targeted therapies and an array of other compelling studies, Drs. Borghaei and Calles decode the implications of these advancements, offering valuable insight into reshaping the future of lung cancer care.
This podcast originally appeared on Healthcare Unfiltered.